X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Journal for ImmunoTherapy of Cancer

期刊標題檢索 J IMMUNOTHER CA 最新評論: Submitted on April 14th, received minor revisions on June 25th, and ... (2026-07-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Journal for ImmunoTherapy of Cancer]您好,您是該頁面的第 151244 位訪客。

期刊簡介
期刊名稱Journal for ImmunoTherapy of Cancer Journal for ImmunoTherapy of Cancer
LetPub Score
8.4
50 ratings
Rate

Reputation
9.4

Influence
7.9

Speed
7.0

期刊簡稱J IMMUNOTHER CANCER
ISSN2051-1426
h-index36
CiteScore
CiteScoreSJRSNIPCiteScore Rank
16.604.1141.932
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q113 / 328
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Oncology
Q127 / 428
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology and Allergy
Q118 / 234
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q114 / 179
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Cancer Research
Q120 / 233
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology
Q122 / 243

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.
官方網站https://jitc.bmj.com/
在線稿件提交https://mc.manuscriptcentral.com/jitc
開放訪問Yes
出版商BMJ PUBLISHING GROUP
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區UNITED STATES
發行頻率
創刊年2013
每年文章數587每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( USD3180; )
APC waiver:Check Notes
Other charges: No
Keywords: tumour immunology、cancer immunotherapy、immunotherapy biomarkers
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ19/183
ONCOLOGYSCIEQ130/333
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-1426%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 18 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Journal for ImmunoTherapy of Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Biomarker ResearchH-index: 0

    CiteScore: 18.50
    Cell Chemical BiologyH-index: 166

    CiteScore: 13.60
    Molecular BiomedicineH-index: 0

    CiteScore: 11.70
    Molecular OncologyH-index: 63

    CiteScore: 9.40
    VIROLOGICA SINICAH-index: 20

    CiteScore: 7.30
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 0

    CiteScore: 6.90
    Biotechnology JournalH-index: 70

    CiteScore: 5.70
    Frontiers in GeneticsH-index: 61

    CiteScore: 6.90
    Pharmacogenomics & Personalized MedicineH-index: 0

    CiteScore: 4.80
    Advances in Biological RegulationH-index: 0

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Genetics533441
    Cell Chemical Biology84374
    Molecular Oncology64514
    Biotechnology Journal48127
    VIROLOGICA SINICA45124
    Biomarker Research42062
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE35873
    Advances in Biological Regulation18814
    Pharmacogenomics & Personalized Medicine18449
    Molecular Biomedicine11062
  •  

    Journal for ImmunoTherapy of Cancer Journal for ImmunoTherapy of Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/12)
  [Journal for ImmunoTherapy of Cancer] 的評論撰寫評論
作者: wnt5a


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2026-07-29 08:03:26 評論於
Submitted on April 14th, received minor revisions on June 25th, and accepted on July 25th. The editor is extremely responsible and of high quality, definitely worth submitting to!
(0) 讚! | wnt5a

作者: 飞猪战神


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-07-27 19:01:08 評論於
20260724 accepted
(0) 讚! | 飞猪战神

作者: 飞猪战神


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-07-20 17:14:53 評論於
Submitted on January 14, 2026, received the first review on March 24, 2026, returned for major revisions on June 15, 2026, requested to submit additional explanations on June 30, 2026, submitted for second review on July 1, 2026, reviewer provided feedback on July 12, 2026. As of July 20, 2026, it is still in "Awaiting Recommendation" status. The outcome is unknown.
(0) 讚! | 飞猪战神

作者: 09loong


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2026-07-03 08:38:27 評論於
The article was submitted on April 24th, sent for external review on May 17th, and rejected on July 1st. The reviewers did not raise any major issues and did not require any additional experiments. However, the editor did not provide any explanation and simply suggested submitting to BMJ Oncology, a journal that is not even indexed in SCI. This lack of respect for our work and the reviewers' opinions is unacceptable, and we will not be submitting to any BMJ-related journals in the future.
(0) 讚! | 09loong

作者: 小王2026


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-06 09:51:33 評論於
Where is the submission website? I can't access the one on the webpage.
(0) 讚! | 小王2026

作者: laerve


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2026-01-25 13:39:41 評論於
Very efficient journal. Top journal in tumor immunology. The content is not complicated, but very novel, belonging to world-first class discoveries. The innovation is average, focusing on the types of biomarkers detected through proteomics analysis. The initial review process is very fast, with revisions given in less than a month. Then, revisions and additional experiments took nearly 2 months. The final review process is slow, taking almost 2 and a half months to receive acceptance. However, this period included Christmas and New Year holidays. The total time from submission to acceptance was over 6 months.
(0) 讚! | laerve

作者: wuxiaoxian


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-06 08:38:24 評論於
So, does the reviewer score determine whether the application is rejected or not?
(0) 讚! | wuxiaoxian

作者: wuxiaoxian


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-06 08:34:49 評論於
So whatever the outcome is, is the "waiting reviewer assignment" still under internal review?
(0) 讚! | wuxiaoxian

作者: SageM


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-16 10:49:41 評論於
Is the editor strict about the word count and number of figures required for the first submission?
(0) 讚! | SageM

作者: SageM


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-16 10:48:34 評論於
Is there a strict requirement for the word count and number of figures for the first submission?
(0) 讚! | SageM

作者: kakafly2022


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-08 16:45:36 評論於
My situation is the same, internal consumption.
(0) 讚! | kakafly2022

作者: 居然99


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-07 23:32:49 評論於
8-15 submitted, 8-26 awaiting reviewer assignment, 8-31 awaiting reviewer scores, 9-7 awaiting recommendation, don't know what's going on, it's been reviewed so quickly, feeling worried...
(0) 讚! | 居然99

作者: Ting子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-02 11:28:33 評論於
It has been a month for me and I am still in the same situation. It's too slow.
(0) 讚! | Ting子

作者: Ting子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-02 11:24:09 評論於
How long does it take for the review?
(0) 讚! | Ting子

作者: Ting子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-02 11:23:02 評論於
It has been a month since submitting the manuscript and it is still in the "Awaiting Section Editor Handling" status. How long did it take for everyone else?
(0) 讚! | Ting子

作者: 特仑酥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-18 16:48:12 評論於
I messed around with the submission system for a while, but it seems like the submission system provided on this website is no longer working. I found a new submission system on the journal's official website. You can try it out at https://mc.manuscriptcentral.com/jitc.
(0) 讚! | 特仑酥

作者: QUER111


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-29 20:50:45 評論於
How long does it take for the status to change after "awaiting reviewer selection"?
(1) 讚! | QUER111

作者: QUER111


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-29 20:50:10 評論於
Is it awaiting reviewer election? It's been a week and there has been no movement.
(0) 讚! | QUER111

作者: jun


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-19 22:44:37 評論於
I am also stuck at this place. How long did you take to finish this stage?
(0) 讚! | jun

作者: jun


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-19 16:20:58 評論於
How long will it take to be allocated in the end?
(0) 讚! | jun

作者: 河马没有角


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-26 09:56:52 評論於
How long does your technical review take?
(0) 讚! | 河马没有角

作者: 河马没有角


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-01-17 15:49:57 評論於
It has been in this state for 11 days, what's going on? Is it this slow?
(0) 讚! | 河马没有角

作者: 河马没有角


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-01-17 15:46:20 評論於
How is it going now? Has the situation changed?
(0) 讚! | 河马没有角

作者: 柑橘辣条胖子


領域: 生物学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-26 09:35:08 評論於
Submitted in mid-March this year, received revision comments in July, was given two months to make revisions, applied for an extension of an additional two months, submitted in early November, and was notified of acceptance of the article half a month later.
(0) 讚! | 柑橘辣条胖子

作者: 哲茂小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-25 21:37:36 評論於
Are you talking about New England?
(0) 讚! | 哲茂小哥哥

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/12)

開始撰寫 [Journal for ImmunoTherapy of Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*